Page 116 - 《中国药房》2024年1期

clearance is associated with inadequate antibiotic pharma‐ methoxazole serum level monitoring in the treatment of
cokinetic/pharmacodynamic target in Asian ICU popula‐ brain abscesses due to Nocardia species[J]. Medicine，
tion：a prospective observational study[J]. Infect Drug Re‐ 2022，101（9）：e28951.
sist，2019，12：2531-2541. [17] 卢张阳，梁培，祁慧，等. 重症患者复方磺胺甲噁唑血药
[10] BARTLETT J G，AUWAERTER P G，PHAM P A.ABX指 峰浓度与不良反应的相关性研究[J]. 中国医院药学杂
南：感染性疾病的诊断与治疗[M]. 北京：科学技术文献 志，2023，43（2）：207-210.
出版社，2018：721. LU Z Y，LIANG P，QI H，et al. The relationships of peak
BARTLETT J G，AUWAERTER P G，PHAM P A.ABX plasma concentration with toxicity of trimethoprim-
guide：diagnose and treatment of infectious diseases [M]. sulfamethoxazole in ICU patients[J]. Chin J Hosp Pharm，
Beijing：Science and Technical Documentation Press， 2023，43（2）：207-210.
2018：721. [18] BROWN G R. Cotrimoxazole-optimal dosing in the criti‐
[11] ROBERTS J A，ABDUL-AZIZ M H，LIPMAN J，et al. In‐ cally ill[J]. Ann Intensive Care，2014，4：13.
dividualised antibiotic dosing for patients who are criti‐ [19] ICE L L，BARRETO J N，DAO B D，et al. Relationship of
cally ill：challenges and potential solutions[J]. Lancet In‐ sulfamethoxazole therapeutic drug monitoring to clinical
fect Dis，2014，14（6）：498-509. efficacy and toxicity：a retrospective cohort study[J]. Ther
[12] ABDUL-AZIZ M H，ALFFENAAR J C，BASSETTI M， Drug Monit，2016，38（3）：319-326.
et al. Antimicrobial therapeutic drug monitoring in criti‐ [20] WANG C W，TASSANEEYAKUL W，CHEN C B，et al.
cally ill adult patients：a Position Paper[J]. Intensive Care Whole genome sequencing identifies genetic variants asso‐
Med，2020，46（6）：1127-1153. ciated with co-trimoxazole hypersensitivity in Asians[J]. J
[13] GUILHAUMOU R，BENABOUD S，BENNIS Y，et al. Allergy Clin Immunol，2021，147（4）：1402-1412.
Optimization of the treatment with beta-lactam antibiotics [21] HUANG Y S，TSENG S Y，CHANG T E，et al.
in critically ill patients-guidelines from the French Society Sulfamethoxazole-trimethoprim-induced liver injury and
of Pharmacology and Therapeutics （Société Française de genetic polymorphisms of NAT2 and CYP2C9 in Taiwan
Pharmacologie et Thérapeutique-SFPT） and the French [J]. Pharmacogenet Genomics，2021，31（9）：200-206.
Society of Anaesthesia and Intensive Care Medicine [22] RECHT J，CHANSAMOUTH V，WHITE N J，et al. Nitro‐
（Société Française d’Anesthésie et Réanimation-SFAR） furantoin and glucose-6-phosphate dehydrogenase defi‐
[J]. Crit Care，2019，23（1）：104. ciency：a safety review[J]. JAC Antimicrob Resist，2022，4
[14] LAMOTH F，ERARD V，ASNER S，et al. High imipenem （3）：dlac045.
blood concentrations associated with toxic encephalopa‐ [23] MILLER A D，BALL A M，BOOKSTAVER P B，et al.
thy in a patient with mild renal dysfunction[J]. Int J Anti‐ Epileptogenic potential of carbapenem agents：mechanism
microb Agents，2009，34（4）：386-388. of action，seizure rates，and clinical considerations[J].
[15] BRICHEUX A，LENGGENHAGER L，HUGHES S，et al. Pharmacotherapy，2011，31（4）：408-423.
Therapeutic drug monitoring of imipenem and the inci‐ [24] RAJPUT J，MOORE L S P，MUGHAL N，et al. Evalua-
dence of toxicity and failure in hospitalized patients：a ting the risk of hyperkalaemia and acute kidney injury
retrospective cohort study[J]. Clin Microbiol Infect，2019， with cotrimoxazole：a retrospective observational study[J].
25（3）：383.e1-383383.e4. Clin Microbiol Infect，2020，26（12）：1651-1657.
[16] CORSINI CAMPIOLI C，ABU SALEH O，MARA K C， （收稿日期：2023-06-30 修回日期：2023-11-26）
et al. Observational study of the clinical utility of sulfa‐ （编辑：刘明伟）

· 106 · China Pharmacy 2024 Vol. 35 No. 1 中国药房 2024年第35卷第1期